Pavone-Macaluso M - Search Results

1

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Lopez-Beltran A, Bassi PF, Pavone-Macaluso M, Montironi R; European Society of Uropathology; Uropathology Working Group. Lopez-Beltran A, et al. Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8. Virchows Arch. 2004. PMID: 15185074 Review.

2

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

3

The pathology of bladder cancer: An update on selected issues.

Pavone-Macaluso M, Lopez-Beltran A, Aragona F, Bassi P, Fitzpatrick JM. Pavone-Macaluso M, et al. BJU Int. 2006 Dec;98(6):1161-5. doi: 10.1111/j.1464-410X.2006.06445.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879435 Review.

4

Interactive computerized morphometric analysis for the differential diagnosis between dysplasia and well differentiated adenocarcinoma of the prostate.

Aragona F, Franco V, Rodolico V, Dardanoni G, Cabibi D, Melloni D, Pavone C, Campesi G, Pavone-Macaluso M. Aragona F, et al. Urol Res. 1989;17(1):35-40. doi: 10.1007/BF00261048. Urol Res. 1989. PMID: 2922889

5

Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).

Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D. Colombo R, et al. Among authors: pavone macaluso m. BJU Int. 2011 Mar;107(6):912-8. doi: 10.1111/j.1464-410X.2010.09654.x. Epub 2010 Oct 4. BJU Int. 2011. PMID: 21029314 Clinical Trial.

6

Transurethral ultrasonography, CT scan, nuclear magnetic resonance (NMR) imaging and pathological control in staging and follow up of invasive bladder carcinoma.

Pavone C, Di Trapani D, Serretta V, Filosto L, Cacciatore M, Caramia G, Pavone-Macaluso M. Pavone C, et al. Prog Clin Biol Res. 1988;260:251-63. Prog Clin Biol Res. 1988. PMID: 3283763

7

Beta-interferon in patients with bladder cancer.

Serretta V, Tripi M, Corselli G, Pavone C, Caramia G, Pavone-Macaluso M. Serretta V, et al. Prog Clin Biol Res. 1988;260:225-8. Prog Clin Biol Res. 1988. PMID: 3362881 No abstract available.

8

Bladder cancer.

Maffezzini M, Audisio R, Pavone-Macaluso M, Hall RR. Maffezzini M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):151-3. doi: 10.1016/s1040-8428(97)10026-9. Crit Rev Oncol Hematol. 1998. PMID: 9571320 Review. No abstract available.

9

The role of epipodophyllotoxin derivatives in bladder cancer.

Serretta V, Ingargiola GB, Pavone-Macaluso M. Serretta V, et al. Semin Oncol. 1992 Apr;19(2 Suppl 6):81-4. Semin Oncol. 1992. PMID: 1411641 Review.

10

Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.

Serretta V, Morgia G, Altieri V, Pavone-Macaluso M, Scuto F, Allegro R, Di Lallo A, Cindolo L, Melloni D; Gruppo Studi Tumori Urologici Foundation. Serretta V, et al. Among authors: pavone macaluso m. Urol Int. 2006;77(2):152-8. doi: 10.1159/000093911. Urol Int. 2006. PMID: 16888422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page